What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Cancer
Her primary areas of study are Internal medicine, Lupus erythematosus, Immunology, Systemic lupus erythematosus and Rheumatology.
Her study on Internal medicine is mostly dedicated to connecting different topics, such as Surgery.
Her research integrates issues of Randomized controlled trial, Family medicine, Systemic disease, Belimumab and Systemic lupus in her study of Lupus erythematosus.
Her Immunology research is multidisciplinary, incorporating elements of Lupus nephritis, Disease, Epidemiology and Cyclophosphamide.
Her Systemic lupus erythematosus research is multidisciplinary, incorporating perspectives in Dermatology and Physical therapy.
Caroline Gordon focuses mostly in the field of Rheumatology, narrowing it down to matters related to Clinical significance and, in some cases, Comorbidity, Derivation, Recursive partitioning and Anti-nuclear antibody.
Her most cited work include:
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2521 citations)
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1437 citations)
- Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus: The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial (913 citations)
What are the main themes of her work throughout her whole career to date?
Caroline Gordon mainly investigates Internal medicine, Immunology, Systemic lupus erythematosus, Lupus erythematosus and Rheumatology.
Her work on Surgery expands to the thematically related Internal medicine.
Her research in Immunology tackles topics such as Lupus nephritis which are related to areas like Cyclophosphamide.
Her Systemic lupus erythematosus research incorporates themes from Dermatology, Clinical trial, Incidence and Rituximab.
Her work investigates the relationship between Lupus erythematosus and topics such as Physical therapy that intersect with problems in Quality of life.
Her Rheumatology study incorporates themes from Disease activity, Alternative medicine, Systemic lupus, Pediatrics and INCEPTION COHORT.
She most often published in these fields:
- Internal medicine (56.96%)
- Immunology (32.39%)
- Systemic lupus erythematosus (28.48%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (56.96%)
- Systemic lupus erythematosus (28.48%)
- Rheumatology (26.30%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Internal medicine, Systemic lupus erythematosus, Rheumatology, Lupus erythematosus and Epidemiology.
Her biological study spans a wide range of topics, including Belimumab and Placebo.
Her Systemic lupus erythematosus research includes elements of Clinical trial, Quality of life, Dermatology, Discoid lupus erythematosus and Rituximab.
Her Rheumatology research is multidisciplinary, relying on both Oncology, Immunology, Systemic lupus, Frailty Index and Confounding.
Her Lupus erythematosus research incorporates elements of Young adult, Lupus nephritis, Disease and Confidence interval.
Many of her studies on Lupus nephritis involve topics that are commonly interrelated, such as Azathioprine.
Between 2018 and 2021, her most popular works were:
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (482 citations)
- Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin (420 citations)
- Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. (37 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Caroline Gordon focuses on Internal medicine, Systemic lupus erythematosus, Lupus erythematosus, Rheumatology and Epidemiology.
She performs integrative Internal medicine and In patient research in her work.
Her Systemic lupus erythematosus research integrates issues from Clinical trial, Adverse effect, Fibromyalgia, Belimumab and Rituximab.
The concepts of her Lupus erythematosus study are interwoven with issues in Lupus nephritis, Disease, Staining and Family medicine.
Caroline Gordon combines subjects such as Systemic lupus, Rheumatoid arthritis, Early Inflammatory Arthritis, Hazard ratio and Frailty Index with her study of Rheumatology.
Caroline Gordon has researched Epidemiology in several fields, including Public health surveillance, Demography and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
